Encompass More Asset Management »

Bridgebio Pharma shares owned by Encompass More Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Encompass More Asset Management from 13F filings

Historical chart of Encompass More Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Encompass More Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Encompass More Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 14k 76.49

More positions owned by Encompass More Asset Management

Northern Lts Fd Tr Iv Main Buywrite (BUYW)
Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
World Gold Tr Spdr Gld Minis (GLDM)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Select Sector Spdr Tr State Street Tec (XLK)
Northern Lts Fd Tr Iv Main Sectr Rotn (SECT)
NVIDIA Corporation (NVDA)
Starboard Invt Tr Adaptive Alpha (AGOX)
Advisorshares Tr Q Dynamic Growth (QPX)
Tesla Motors (TSLA)
Vaneck Etf Trust Gold Miners Etf (GDX)
Innovator Etfs Trust Growth 100 Power (NSEP)

View all positions for Encompass More Asset Management

Top funds holding Bridgebio Pharma

Vanguard Group
BlackRock
Viking Global Investors
Kohlberg Kravis Roberts & Co
Farallon Capital Management
UBS Group
Aisling Capital Management
State Street Corporation
Invesco
Geode Capital Management
Jane Street
Susquehanna International
Frazier Life Sciences Management
FMR
Wellington Management Company

View all funds holding Bridgebio Pharma